Akesa, a pioneering Australia-based clinical trial supply company, has announced a strategic partnership with Rock8 Science to strengthen pharmaceutical supply chains in the Asia-Pacific.
The collaboration addresses the increasing demand for commercial medicines in clinical trial settings, ensuring studies across APAC have reliable access to essential pharmaceutical products.
Akesa Co-CEO Con Konstantopoulos said the partnership would support pharmaceutical manufacturers in managing increasing clinical trial demand while enabling a more transparent, efficient, and sustainable supply chain.
“”At present, many manufacturers don’t have visibility over how their products are being used in clinical trials, making it difficult to accurately predict demand and prevent supply disruptions,” Konstantopoulos said.
The partnership enables pharmaceutical manufacturers to better anticipate trial-related demand fluctuations through real-time insights, helping reduce the risk of supply disruptions and commercial stock shortages.
“Expanding our reach in APAC is vital to supporting sponsors, CDMOs and CROs with compliant, scalable access to trial medicines,” Konstantopoulos added. “This collaboration helps bridge a longstanding gap—connecting clinical demand with commercial supply strategies to ensure continuity and avoid delays.”
With more than half the world’s population, the APAC region continues to attract pharmaceutical investment due to its diverse patient base, cost efficiencies, and accelerated recruitment timelines.
Susan Heeley, Managing Director of Rock8 Science, said: “As more pharmaceutical companies prioritise APAC for clinical research, efficient medicine access remains a bottleneck. This partnership ensures products are available when and where they’re needed—ultimately supporting research that drives better global health outcomes.”
About
Akesa
Founded in 2014, Akesa is a leading clinical trial supply and pharmaceutical services company based in Australia.
With a deep understanding of the APAC market, the company provides tailored sourcing, procurement, and logistics solutions to support clinical research across the region and globally.
Akesa’s expertise in pharmaceutical distribution and supply chain management ensures that clinical trials have access to the critical medicines they need.
Rock8 Science
Founded by pharmaceutical executives Charles and Susan Heely, Rock8 Science is a specialist healthcare consulting firm that provides business development, commercial strategy, account management, and enterprise partnership services.
With deep industry expertise and strong connections across the pharmaceutical sector, Rock8 works with clients to drive strategic growth, optimise supply networks, and strengthen market positioning.
Learn more at www.rock8science.com
